First Header Logo Second Header Logo

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.

Fehniger TA, Larson S, Trinkaus K, Siegel MJ, Cashen AF, Blum KA, Fenske TS, Hurd DD, Goy A, Schneider SE, Keppel CR, Wagner-Johnston ND, Carson KR, Bartlett NL. A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma. Blood. 2011 Nov 10; 118(19):5119-25.

View in: PubMed